Insider Activity · SEC Form 4
Anteris Technologies Global Corp. (AVR) Insider Trading
Anteris Technologies is an Australian-listed cardiovascular device company developing the DurAVR transcatheter aortic valve — a single-piece bovine pericardium TAVR designed to replicate native valve hemodynamics. Clinical-stage with ongoing US pivotal trial; TAVR market entry is the defining milest
Buys: 0 · —
Sales: 5 · $23.57M
Recent insider transactions
| Insider | Type | Shares | Price | Value | Date | Source |
|---|---|---|---|---|---|---|
| L1 Capital Pty Ltd10% Owner | SELL | 627,659 | $9.22 | $5.79M | Aug 11, 2026 | Form 4 → |
| L1 Capital Pty Ltd10% Owner | SELL | 495,189 | $8.30 | $4.11M | Aug 5, 2026 | Form 4 → |
| L1 Capital Pty Ltd10% Owner | SELL | 524,404 | $8.10 | $4.25M | Aug 3, 2026 | Form 4 → |
| L1 Capital Pty Ltd10% Owner | SELL | 714,138 | $8.17 | $5.83M | Jul 30, 2026 | Form 4 → |
| L1 Capital Pty Ltd10% Owner | SELL | 441,548 | $8.14 | $3.60M | Jul 28, 2026 | Form 4 → |
Recent SEC filings
| Filing | Date | Source |
|---|---|---|
| 8-KAnteris Technologies Global Corp. | Sep 8, 2026 | Filing → |
| 8-KAnteris Technologies Global Corp. | Aug 11, 2026 | Filing → |
| 8-KAnteris Technologies Global Corp. | Aug 3, 2026 | Filing → |
| 8-KAnteris Technologies Global Corp. | Jul 31, 2026 | Filing → |
| 8-KAnteris Technologies Global Corp. | May 22, 2026 | Filing → |